Residual symptoms and lower lung function in patients recovering from SARS-CoV-2 infection
Open Access
- 21 January 2021
- journal article
- letter
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 57 (2), 2003002
- https://doi.org/10.1183/13993003.03002-2020
Abstract
About half of the patients recovering from SARS-CoV-2 have persistent symptoms and reduced lung function as long as 2 months after infection. This is common even in younger SARS-CoV-2 convalescents with few comorbidities.This publication has 21 references indexed in Scilit:
- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, ChinaJAMA, 2020
- Long-term bone and lung consequences associated with hospital-acquired severe acute respiratory syndrome: a 15-year follow-up from a prospective cohort studyBone Research, 2020
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, ChinaThe Lancet, 2020
- The Global Lung Function Initiative (GLI) Network: bringing the world’s respiratory reference values togetherBreathe, 2017
- Prevalence of Small-Airway Dysfunction among COPD Patients with Different GOLD Stages and Its Role in the Impact of DiseaseRespiration, 2016
- Chronic widespread musculoskeletal pain, fatigue, depression and disordered sleep in chronic post-SARS syndrome; a case-controlled studyBMC Neurology, 2011
- Mental Morbidities and Chronic Fatigue in Severe Acute Respiratory Syndrome SurvivorsArchives of Internal Medicine, 2009
- Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society.1993
- Lung volumes and forced ventilatory flowsEuropean Respiratory Journal, 1993
- Pulmonary mechanics after uncomplicated influenza A infection.Published by Elsevier BV ,1976